Medical Device News Magazine

Successful in vivo Pilot Study of MOBYBOX™ by Minnesota Resuscitation Consortium (MRC), Which is Developing a ‘Super Ambulance’ Equipped to Advance Cardiac Arrest Treatment

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Hemovent GmbH announced today that its next-generation ECMO (ExtraCorporeal Membrane Oxygenation) system, MOBYBOX, has been validated in a pilot in vivo study by Minnesota Resuscitation Consortium, which is designing a ‘super ambulance’ that will be equipped with the latest technology to advance treatment of cardiac-arrest emergency patients.

A ‘super ambulance’ will be equipped with vascular and cardiac imaging, such as fluoroscopy and echocardiography, 3D immersion telemedicine capability, as well as heart/lung bypass technology, such as MOBYBOX, in order to pare precious minutes off the time it takes for a heart attack or respiratory failure patient to be treated. The ‘super ambulance’ program is being led by cardiologist Demetri Yannopoulos, M.D., professor of medicine, interventional cardiologist, and director of the Center for Resuscitation Medicine at the University of Minnesota.

“Being asked by Dr. Yannopoulos to include MOBYBOX in his ‘mobile ECMO’ concept underscores the potential commercial opportunity for MOBYBOX, which is positioned to disrupt a billion-dollar international market whose standard therapy is complex to use, costly to purchase, and not really portable,” said Christof Lenz, a co-founder and CEO of Hemovent.

Hemovent has previously announced it has successfully completed a GLP standardized in vivo study for long-term (7 days) use of its MOBYBOX system, designed for a wide range of indications: from ExtraCorporeal Life Support (ECLS) to ExtraCorporeal CO2 Removal (ECCO2R).

Hemovent is an emerging medical device company with a proprietary platform technology for heart and lung support. Its first product, MOBYBOX, is a self-contained, fully integrated ExtraCorporeal Membrane Oxygenation (ECMO) / ExtraCorporeal Life Support (ECLS) device designed with an ultimate focus on safety, ease of use, mobility, and performance in order to support or replace heart and lung function in the event of cardiac and/or respiratory failure.

CAUTION: The Hemovent ECMO/ ECLS System is not approved for human use yet.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.